MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Transition Therapeutics Company Profile (NASDAQ:TTHI)

Consensus Ratings for Transition Therapeutics (NASDAQ:TTHI) (?)
Ratings Breakdown: 2 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.50 (97.37% upside)

Analysts' Ratings History for Transition Therapeutics (NASDAQ:TTHI)
Show:
DateFirmActionRatingPrice TargetActions
5/14/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015HC WainwrightReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/26/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha